Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis

New England Journal of Medicine

Volumn 342, Issue 8, 2000, Pages 534-540

  Carey, J Christopher ^a   Klebanoff, Mark A ^b   Hauth, John C ^c   Hillier, Sharon L ^d   Thom, Elizabeth A ^e   Ernest, J M ^f   Heine, R Phillip ^d   Nugent, Robert P ^b   Fischer, Molly L ^e   Leveno, Kenneth J ^g   Wapner, Ronald ⁿ   Varner, Michael ^h   Trout, Wayne ⁱ   Moawad, Atef ^j   Sibai, Baha M ^k   Miodovnik, Menachem ⁿ   Dombrowski, Mitchell ⁿ   O'Sullivan, Mary J ⁿ   VanDorsten, J Peter ^l   Langer, Oded ^m   Roberts, James ^d   more..

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e GEORGE WASHINGTON UNIVERSITY   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^h UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

ⁱ OHIO STATE UNIVERSITY   (United States)

^j UNIVERSITY OF CHICAGO   (United States)

^k UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^l MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^m UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

ⁿ University of Texas at San Antonio ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE; PLACEBO;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG INDUCED DISEASE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TRICHOMONAS VAGINALIS; VAGINITIS;

ADULT; ANTI-INFECTIVE AGENTS; DISEASE-FREE SURVIVAL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFANT, NEWBORN; METRONIDAZOLE; OBSTETRIC LABOR, PREMATURE; PATIENT COMPLIANCE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; TREATMENT OUTCOME; VAGINOSIS, BACTERIAL;

EID: 0033995348     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200002243420802     Document Type: Article

References (21)

1. Gibbs RS, Romero R, Hillier SL, Eschenbach DA, Sweet RL. A review of premature birth and subclinical infection. Am J Obstet Gynecol 1992; 166:1515-28.
2. Driscoll SG. Significance of acute chorioamnionitis. Clin Obstet Gynecol 1979;22:339-49.
3. Hillier SL, Martius J, Krohn M, Kiviat N, Holmes KK, Eschenbach DA. A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med 1988;319:972-8.
4. Hauth JC, Andrews WW, Goldenberg RL. Infection-related risk factors predictive of spontaneous preterm labor and birth. Prenat Neonat Med 1998;3:86-90.
5. Romero R, Mazor M. Infection and preterm labor. Clin Obstet Gynecol 1988;31:553-84.
6. Graven MG, Nelson HP, DeRouen T, Critchlow C, Eschenbach DA, Holmes KK. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA 1986;256: 1899-903.
7. McDonald HM, O'Loughlin JA, Jolley P, Vigneswaran R, McDonald PJ. Prenatal microbiological risk factors associated with preterm birth. Br J Obstet Gynaecol 1992;99:190-6.
8. Hillier SL, Nugent RP, Eschenbach DA, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. N Engl J Med 1995;333:1737-42.
9. Goldenberg RL, Andrews WW, Yuan AC, MacKay HT, St Louis ME. Sexually transmitted diseases and adverse outcomes of pregnancy. Clin Perinatol 1997;24:23-41.
10. Meis PJ, Goldenberg RL, Mercer B, et al. The preterm prediction study: significance of vaginal infections. Am J Obstet Gynecol 1995;173: 1231-5.
11. Morales WJ, Schorr S, Albritton J. Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study. Am J Obstet Gynecol 1994;171:345-7.
12. McDonald HM, O'Loughlin JA, Vigneswaran R, et al. Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): a randomised, placebo controlled trial. Br J Obstet Gynaecol 1997;104:1391-7.
13. Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Cooper RL. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995;333:1732-6.
14. Joesoef MR, Hillier SL, Wiknjosastro G, et al. Intravaginal clindamycin treatment for bacterial vaginosis: effects on preterm delivery and low birth weight. Am J Obstet Gynecol 1995;173:1527-31.
15. McGregor JA, French JI, Jones W, et al. Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream. Am J Obstet Gynecol 1994; 170:1048-60.
16. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991;29:297-301.
17. Lugo-Miro VI, Green M, Mazur L. Comparison of different metronidazole therapeutic regimens for bacterial vaginosis: a meta-analysis. JAMA 1992;268:92-5.
18. Wei LJ, Lachin JM. Properties of the urn randomization in clinical trials. Controlled Clin Trials 1988;9:345-64.
19. Cnaan A, Ryan L. Survival analysis in natural history studies of disease. Stat Med 1989;8:1255-68.
20. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983;70:659-63.
21. Goldenberg RL, Andrews WW. Intrauterine infection and why pre-term prevention programs have failed. Am J Public Health 1996;86:781-3.